Follow-up after curative resection of colorectal cancer: A meta-analysis

被引:258
作者
Tjandra, Joe J.
Chan, Miranda K. Y.
机构
[1] Caritas Med Ctr, Dept Surg, Sham Shui Po, Hong Kong, Peoples R China
[2] Univ Melbourne, Royal Melbourne Hosp, Dept Colorectal Surg, Melbourne, Vic 3050, Australia
[3] Univ Melbourne, Epworth Hosp, Melbourne, Vic, Australia
关键词
follow-up; surveillance; colorectal cancer; recurrence;
D O I
10.1007/s10350-007-9030-5
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Purpose: This is a systematic review to evaluate the impact of various follow-up intensities and strategies on the outcome of patients after curative surgery for colorectal cancer. Methods: All randomized trials up to January 2007, comparing different follow-up intensities and strategies, were retrieved. Meta-analysis was performed by using the Forest plot review. Results: Eight randomized, clinical trials with 2,923 patients with colorectal cancer undergoing curative resection were reviewed. There was a significant reduction in overall mortality in patients having intensive follow-up (intensive vs. less intensive follow-up: 21.8 vs. 25.7 percent; P=0.01). Regular surveillance with serum carcinoembryonic antigen (P=0.0002) and colonoscopy (P=0.04) demonstrated a significant impact on overall mortality. However, cancer-related mortality did not show any significant difference. There was no significant difference in all-site recurrence and in local or distant metastasis. Detection of isolated local and hepatic recurrences was similar. Intensive follow-up detected asymptomatic recurrence more frequently (18.9 vs. 6.3 percent; P < 0.00001) and 5.91 months earlier than less intensive follow-up protocol; these were demonstrated with all investigation strategies used. Intensive surveillance program detected recurrences that were significantly more amenable to surgical reresection (10.7 vs. 5.7 percent; P=0.0002). The chance of curative reresection were significantly better with more intensive follow-up (24.3 vs. 9.9 percent; P=0.0001), independent of the investigation strategies used. Conclusions: Intensive follow-up after curative resection of colorectal cancer improved overall survival and reresection rate for recurrent disease. However, the cancer-related mortality was not improved and the survival benefit was not related to earlier detection and treatment of recurrent disease.
引用
收藏
页码:1783 / 1799
页数:17
相关论文
共 58 条
[1]  
[Anonymous], ANZ J SURG S
[2]   Surveillance of colorectal cancer - Effectiveness of early detection of intraluminal recurrences on prognosis and survival of patients treated for cure [J].
Barillari, P ;
Ramacciato, G ;
Manetti, G ;
Bovino, A ;
Sammartino, P ;
Stipa, V .
DISEASES OF THE COLON & RECTUM, 1996, 39 (04) :388-393
[3]   Surveillance after colorectal cancer resection [J].
Berman, JM ;
Cheung, RJ ;
Weinberg, DS .
LANCET, 2000, 355 (9201) :395-399
[4]   DOES METHODIC LONG-TERM FOLLOW-UP AFFECT SURVIVAL AFTER CURATIVE RESECTION OF COLORECTAL-CARCINOMA [J].
BOHM, B ;
SCHWENK, W ;
HUCKE, HP ;
STOCK, W .
DISEASES OF THE COLON & RECTUM, 1993, 36 (03) :280-286
[5]   FOLLOW-UP OF PATIENTS WITH COLORECTAL-CANCER - A METAANALYSIS [J].
BRUINVELS, DJ ;
STIGGELBOUT, AM ;
KIEVIT, J ;
VANHOUWELINGEN, HC ;
HABBEMA, JDF ;
VANDEVELDE, CJH .
ANNALS OF SURGERY, 1994, 219 (02) :174-182
[6]  
*COCHR COLL, 2002, REV MAN REVMAN US GU
[7]   INCIDENCE OF SYNCHRONOUS AND METACHRONOUS COLORECTAL-CARCINOMA [J].
CUNLIFFE, WJ ;
HASLETON, PS ;
TWEEDLE, DEF ;
SCHOFIELD, PF .
BRITISH JOURNAL OF SURGERY, 1984, 71 (12) :941-943
[8]   Randomised trial of irinotecan plus supportive care versus supportive care alone after fluorouracil failure for patients with metastatic colorectal cancer [J].
Cunningham, D ;
Pyrhönen, S ;
James, RD ;
Punt, CJA ;
Hickish, TF ;
Heikkila, R ;
Johannesen, TB ;
Starkhammar, H ;
Topham, CA ;
Awad, L ;
Jacques, C ;
Herait, P .
LANCET, 1998, 352 (9138) :1413-1418
[9]  
Delpero JR, 1998, BRIT J SURG, V85, P372
[10]   Cancer physicians' attitudes toward colorectal cancer follow-up [J].
Earle, CC ;
Grunfeld, E ;
Coyle, D ;
Cripps, MC ;
Stern, HS .
ANNALS OF ONCOLOGY, 2003, 14 (03) :400-405